Increasing exercise capacity and physical activity in the COPD patient.


Journal

Breathe (Sheffield, England)
ISSN: 1810-6838
Titre abrégé: Breathe (Sheff)
Pays: England
ID NLM: 101231007

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 19 12 2023
accepted: 24 04 2024
medline: 14 6 2024
pubmed: 14 6 2024
entrez: 14 6 2024
Statut: epublish

Résumé

Higher levels of exercise capacity and physical activity are desired outcomes in the comprehensive management of the COPD patient. In addition, improvements in exercise capacity and physical activity are instrumental to optimising other important therapeutic goals, such as improved health status, reduced healthcare utilisation and increased survival. Four general approaches towards increasing exercise capacity and physical activity in individuals with COPD will be discussed in this review: 1) pharmacological intervention, especially the administration of long-acting bronchodilators; 2) pulmonary rehabilitation, including exercise training and collaborative self-management; 3) behavioural interventions; and 4) web-based interventions. These are by no means the only approaches, nor are they mutually exclusive: indeed, combining them, as necessary, to meet the needs of the individual respiratory patient may promote optimal outcomes, although further research is necessary in this area.

Identifiants

pubmed: 38873235
doi: 10.1183/20734735.0347-2023
pii: EDU-0347-2023
pmc: PMC11167654
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

230347

Informations de copyright

Copyright ©ERS 2024.

Déclaration de conflit d'intérêts

Conflict of interest: J. Bourbeau reports grants from McGill University, the McGill University Health Centre Foundation, the Canadian Institutes of Health Research, Grifols, Novartis, Sanofi, and the Respiratory Health Network of the Fonds de la recherche en santé du Québec; grants and personal fees from AstraZeneca Canada Ltd, Boehringer Ingelheim Canada Ltd, GlaxoSmithKline Canada Ltd, and Trudell Canada Ltd; and personal fees from Pfizer Canada Ltd, and COVIS Pharma Canada Ltd, outside the submitted work. L. Brighton reports funding from an Economic and Social Research Council Post-Doctoral Fellowship (ES/X005259/1), outside the submitted work. S. Singh reports being a National Institute for Health Research (NIHR) Senior Investigator. This work was supported by the NIHR Leicester Biomedical Research Centre (BRC). The views expressed in this article are those of the author(s) and not necessarily those of the NIHR, or the Department of Health and Social Care. The remaining authors have nothing to disclose.

Auteurs

Antarpreet Kaur (A)

Section of Pulmonary, Interventional Pulmonary, Critical Care, and Sleep Medicine, Saint Francis Hospital and Medical Center, Hartford, CT, USA.

Jean Bourbeau (J)

Respiratory Epidemiology and Clinical Research Unit, Department of Medicine, McGill University Health Centre (MUHC), Montreal, QC, Canada.

Lisa Brighton (L)

Cicely Saunders Institute of Palliative Care, Policy and Rehabilitation, King's College London, London, UK.

Bartolome Celli (B)

Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Rebecca Crouch (R)

Duke University Hospital and Medical Center, Department of Physical and Occupational Therapy, Durham, NC, USA.

Heleen Demeyer (H)

Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.
Department of Rehabilitation Sciences, Ghent University, Ghent, Belgium.

Daniel A Gerardi (DA)

Section of Pulmonary, Interventional Pulmonary, Critical Care, and Sleep Medicine, Saint Francis Hospital and Medical Center, Hartford, CT, USA.

Hideki Katsura (H)

Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.

Paula Meek (P)

University of Utah College of Nursing, Salt Lake City, UT, USA.

Mike Morgan (M)

Retired, Department of Respiratory Sciences, University of Leicester, Biomedical Research Centre, Leicester, UK.

Mara Paneroni (M)

Istituti Clinici Scientifici Maugeri IRCCS, Respiratory Rehabilitation Unit of the Institute of Lumezzane, Brescia, Italy.

Sally Singh (S)

Department of Respiratory Sciences, University of Leicester, Biomedical Research Centre, Leicester, UK.

Michael K Stickland (MK)

Division of Pulmonary Medicine, Department of Medicine, University of Alberta and G.F. MacDonald Centre for Lung Health (Covenant Health), Edmonton, AB, Canada.

Classifications MeSH